CONSOLIDATED STATEMENTS OF EQUITY - USD ($) $ in Millions		Total	Common Stock	Preferred Stock	Cumulative effect of accounting change	[2]	Common Stock	Preferred Stock	Preferred Stock Preferred Stock	Additional Paid-in Capital	Additional Paid-in Capital Common Stock	Additional Paid-in Capital Preferred Stock	Additional Paid-in Capital Cumulative effect of accounting change	[2]	Treasury Stock	Retained Earnings	Retained Earnings Cumulative effect of accounting change	[2]	Accumulated Other Comprehensive (Loss) Income	Noncontrolling Interests
Beginning Balance at Dec. 31, 2019		$ 1,232.4					$ 0.4	$ 0.0		$ 762.8					$ 0.0	$ 500.3			$ (35.9)	$ 4.8
Beginning balance (shares) at Dec. 31, 2019							35,800,000
Preferred stock balance at the beginning (in shares) at Dec. 31, 2019								0
Increase (Decrease) in Stockholders' Equity
Net income		309.5														308.1				1.4
Other comprehensive loss		38.3																	38.3
Share-based compensation expense		8.9								8.9
Common stock issued from share-based compensation plans		11.0								11.0
Common stock issued from share-based compensation plans (shares)							420,000
Common stock repurchases from share-based compensation plans		(1.9)								(1.9)
Common stock repurchases from share-based compensation plan (shares)							(30,000.00)
Common stock repurchases	[1]	(19.3)													(19.3)
Other		(0.4)																		0.4
Ending Balance at Dec. 31, 2020		1,579.3			$ (26.2)		$ 0.4	$ 0.0		780.8			$ (36.9)		(19.3)	808.4	$ 10.7		2.4	6.6
Ending balance (shares) at Dec. 31, 2020							36,190,000
Preferred stock balance at the end (in shares) at Dec. 31, 2020								0
Increase (Decrease) in Stockholders' Equity
Net income		60.9														59.1				1.8
Other comprehensive loss		(24.1)																	(24.1)
Share-based compensation expense		11.2								11.2
Common stock issued from share-based compensation plans		6.9								6.9
Common stock issued from share-based compensation plans (shares)							260,000
Common stock repurchases from share-based compensation plans		(6.4)								(6.4)
Common stock repurchases from share-based compensation plan (shares)							(40,000.00)
Acquisition of Earthly Labs Inc.		23.4								23.4
Acquisition of Earthly Labs Inc. (in shares)							140,000
Other		0.2																		0.2
Ending Balance at Dec. 31, 2021		$ 1,625.2					$ 0.4	$ 0.0		779.0					(19.3)	878.2			(21.7)	8.6
Ending balance (shares) at Dec. 31, 2021		36,548,330					36,550,000
Preferred stock balance at the end (in shares) at Dec. 31, 2021		0						0
Increase (Decrease) in Stockholders' Equity
Net income		$ 25.0														24.0				1.0
Other comprehensive loss		(36.3)																	(36.3)
Share-based compensation expense		10.6								10.6
Common stock issued from share-based compensation plans		$ 2.2								2.2
Common stock issued from share-based compensation plans (shares)		30,000.00					110,000
Common stock repurchases from share-based compensation plans		$ (3.6)								(3.6)
Common stock repurchases from share-based compensation plan (shares)							(20,000.00)
Stock issuance, net of equity issuance costs			$ 675.1	$ 388.1							$ 675.1	$ 388.1
Stock issuance, net of equity issuance costs (shares)							5,920,000		400,000
Acquisition of Earthly Labs Inc.		(1.2)								(1.2)
Other		(0.8)																		(0.8)
Ending Balance at Dec. 31, 2022		$ 2,684.3					$ 0.4	$ 0.0		$ 1,850.2					$ (19.3)	$ 902.2			$ (58.0)	$ 8.8
Ending balance (shares) at Dec. 31, 2022		42,563,032					42,560,000
Preferred stock balance at the end (in shares) at Dec. 31, 2022		402,500						400,000

[1] Includes $19.3 in shares repurchased through our share repurchase program. Refer to Note 2, “Significant Accounting Policies,” for further information.

[2] Refer to Note 2, “Significant Accounting Policies” for discussion regarding cumulative effect of change in accounting principle.